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ABSTRACT
USING A COST BENEFIT ANALYSIS TO SUPPORT THE DEVELOPMENT
OF A COMPREHENSIVE BUSINESS MODEL FOR A PRE-FILLED,
PRE-LABELED, PRE-DILUTED, STERILELY PACKAGED,
READY-TO-USE, SYRINGE-BASED ANESTHESIA
DELIVERY SYSTEM
by Lance Brandon Kennedy
December 2015
The foundation of Certified Registered Nurse Anesthetists’ (CRNAs) entire
profession is built on the ability to provide anesthetic services using a variety of
medications in the safest, most efficient, cost-effective way possible. The purpose of this
capstone is to address, via a comprehensive cost benefit analysis, whether pre-filled
syringe drug trays are a more cost-effective way to address problems as compared to vialfilled drug trays and to implement the necessary transitions in order to improve outcomes.
There are a number of identifiable problems related to anesthesia medication delivery via
vial-filled medication, including increased cost of healthcare, decreased patient safety to
provider inconvenience, increased medication errors, and increased contamination. The
method of medication delivery has gained the attention of significant governing bodies
such as the Joint Commission of Healthcare Organizations (JCAHO), Centers for Disease
Control (CDC), and American Association of Nurse Anesthetists (AANA), just to name a
few. The best methods for change were evaluated in order to facilitate the most optimal
quality improvement. According to the AANA, “the available information is sufficient to
promote the implementation of pre-filled or premixed syringes in anesthesia departments
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to reduce the number of adverse drug events (ADEs) and become compliant with the
Joint Commission, and Institute of Medicine” (Brown, 2014, pp. 465-469).
The future change in anesthesia drug delivery is undeniable, and the data provide
clearly defined recommendations and guidelines supporting the use of pre-filed syringes.
Providing medications in pre-filled syringes would reduce medication errors and
treatment delays, improve patient safety, and effectively meet the expectations,
recommendations, and guidelines of governing entities (Fahimi et al., 2008). “When you
look at the impact of the initiative on quality and safety for the patients, it’s [just] what’s
right to do” (Blum, 2013, p. 3).
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CHAPTER I
INTRODUCTION
Statement of the Problem
Imagine, for a moment, a happy and mischievous four-year-old little boy, full of
life and laughter. His name is Jacobi Hill. Imagine his big brown eyes lighting up as he
lets out an infectious laugh. Imagine his contagious smile as he hid his mom’s car keys,
as he often did (Burns, 2010). Imagine a cool crisp morning as his parents take him for
‘routine’ dental surgery. Fast-forward to the OR and now imagine this dream turns into a
nightmare. Imagine his anesthesia provider struggling to ventilate the little boy after he
has been rendered incapable of protecting his own airway. The anesthesiologist’s left
hand is firmly securing the mask to the little boys face, and his right hand is applying
positive pressure to the bag attempting to break what is seemingly a laryngospasm, but he
is still unable to ventilate. Anyone in anesthesia knows that this little boy needs a lifesaving, short acting paralytic, like succinylcholine. The problem is that at this point, it
would require it to be “drawn up” from the vial and with both hands occupied, someone
else, less familiar with the drugs and too inexperienced to prepare the drug quickly and
safely, must attempt to do so when every second that passes is another second without
oxygen. The little boy is finally given the appropriate medication, intubated, and taken to
intensive care unit where he remains for the next few days until he eventually dies. This
is so tragic, but the worst part is that it was potentially preventable. Had there been a
system in place that would allow immediate administration of life-saving drugs without
the risk of medication waste and medication errors, perhaps little Jacobi Hill still be alive.
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Background and Significance
The intent of this comprehensive cost benefit analysis is to provide the highest
quality medical supplies to healthcare providers in order to improve the quality of
healthcare. Identifiable problems related to anesthesia medication delivery via vial-filled
medication include: (1) Significant increased healthcare cost related to medication waste
and dilutional drug errors (U.S. National library of Medicine National Institute of Health,
2011); (2) Increased possibility of contamination and infection due to drawing up
medication without the use of a sterility hood, while frequently under hurried conditions.
Also, some medications have a very short time to expiration when drawn up by the
provider, as opposed to under sterile pharmacy conditions (Fahimi et al., 2008); and (3)
During an acute condition such as a laryngospasm, hypotension, or bradycardia, time to
draw up emergency drugs takes away precious time from the patient, and can result in
frightful negative outcomes (Adapa et al., 2012).
Additionally, governing entities such as the Joint Commission, CDC, and the
AANA have recommendations and guidelines that support pre-filled syringes, and make
it virtually impossible to practice without using them. The 2010 National Patient Safety
Goals state that “when a drug is drawn into a syringe or otherwise used from its original
container it must be immediately administered. ‘Immediate administration’ means with
no intervening steps or functions prior to administration” (The 2010 National Patient
Safety Goals, 2010, p. 5). The CDC Infection Prevention Checklist for Outpatient
Settings: Minimum Expectations for Safe Care states that “Injections [should be]
prepared using aseptic technique in a clean area free from contamination or contact with
blood, body fluids or contaminated equipment” (CDC, 2013, p. 6). This means that
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medication should be drawn and labeled outside of patient areas, including the operating
room. Furthermore, according to the AANA (2014), the use of pre-filled or premixed
medication and electronic documentation have been shown to reduce the number of
Adverse Drug Events (ADEs) by as much as 21%, and, according to the IOM,
approximately $2 billion is spent annually on ADEs in hospital settings. This would
mean a $420,000,000 decrease in healthcare cost just on ADEs alone. Moreover, the Joint
Commission standard MM.05.01.07 states that medication preparation should either be
done by a pharmacist or under the direct supervision of a pharmacist. The AANA
concludes that the savings justifies the cost, and “the available information is sufficient to
promote the implementation of pre-filled or premixed syringes in anesthesia departments
to reduce the number of adverse drug events and become compliant with the Joint
Commission, and Institute of Medicine” (Brown, 2014, pp. 465-469).
Each of these problems has a significant cost attached to them. If anesthesia
providers would be willing to make an effort to move toward compliance with the
governing bodies’ guidelines and recommendations, they would simultaneously promote
safety, improve outcomes, and decrease the cost of healthcare. The purpose of the
capstone is to address, via a comprehensive cost benefit analysis, whether pre-filled
syringe drug trays are a more cost-effective way to address these problems as compared
to vial-filled drug trays and, if so, to find methods to implement necessary transitions.
Concept Analysis
Anesthesia medication delivery affects the lives of every patient who ever needs
to undergo surgery and require anesthetic services. In constructing a concept analysis,
the first step is selecting a concept, then determining the aim of the analysis, followed by
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identifying uses for the concept, determining the defining attributes, identifying model
cases, antecedents, and consequences, and finally, defining empirical referents (Butts &
Rich, 2015). Two models are used to evaluate the differences between vial-filled
anesthesia drug trays and pre-filled syringe anesthesia drug trays. The first quality
improvement model utilized is the Plan-Do-Study-Act (PDSA) cycle (The Deming
Institute, 2013). PDSA is a four-tier problem-solving model used for quality
improvement. When applying the PDSA model it is important to consider what our goal
is and to consider if the change is an improvement. The goal is to develop a
comprehensive business model for a pre-filled, pre-labeled, pre-diluted, sterilely
packaged, ready-to-use syringe based anesthesia delivery system. A cost benefit analysis
will identify and validate the results of the syringe based anesthesia delivery system, and
determine that it is indeed a substantial improvement.
The PDSA model has two cycles. Cycle one involved the planning phase,
including brainstorming and implementing the proposed changes to improve the
anesthesia drug delivery to improve outcomes via pre-filled, pre-diluted, sterilely
packaged, ready-to-use syringes in an anesthesia delivery system. Next, commonly used
drugs, their dilutions, and their organization and cost, were identified and compared
against pre-filled syringes.
The results were then analyzed, costs were compared, and evidence identified an
obvious cost benefit in multiple areas including medication waste, medication errors,
decreased time of anesthetic induction, and increased patient safety. Further study is
needed to identify more specifically how much dilutional errors cost on a national,
regional, and local facility level, but, approximately $2 billion is spent annually on ADEs
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in hospital settings, and the AANA cites the use of pre-filled syringes to decrease this by
as much as 21% (Brown, 2014, pp. 465-469). Therefore, healthcare costs stand to be
decreased, at the very least $420,000,000 annually. The final portion of this model
involved initiating a business plan and the considering of standardization options. Once
cycle one is complete and results are analyzed, the PDSA cycle 2 can begin and an
evaluation can be made to consider which areas were successful and which areas were
not.
The second model used to evaluate the difference between vial-filled medication
trays and pre-filled medication trays pertains to transitions within professional practice.
The transition process begins when life events create the need for change. The
management of these transitions has profound effects on life, well-being, and health. The
transitions model can be used to optimize the nursing profession and better prepare
nurses to work efficiently in a diverse healthcare system (Young and Wilkerson, 2010).
There are three phases in the concept of the Transitions Model according to
Young and Wilkerson (2000). Phase one is the ‘ending phase’, which is the release of
familiar ways. The ending phase requires the person in transition to recognize the need
for change, and be willing to let go of the status quo to step outside of their comfort zone
and be open to other possibilities. The second phase is the ‘neutral phase’ and it involves
ambiguity and disequilibrium. Here, accustomed ideas are disrupted and lost, and the
transitions require the use of personal, interpersonal, and various environmental means to
assist the change process. The third phase is the ‘reorientation phase’. In this phase,
feelings of synchronization and harmony are restored, creating new meaning and
independence. There is an acceptance of the new challenges and a sense of ownership in

6
the new situation. Positive outcomes include restitution, encouragement, security, and
preservation. Change is difficult and often resisted, however, change is necessary in
order to grow and improve outcomes (Young and Wilkerson, 2010).
The cost of healthcare is increasing due to preventable problems associated with the
system and policy, or lack thereof, which hinders improved outcomes. One example
would be when an anesthetized patient has an episode of bradycardia in response to the
surgeon manipulating the vagus nerve. In response to that bradycardia the anesthesia
provider removes the top from the vial and draws up the atropine. Then, as commonly
happens, the surgeon stops manipulating the vagus nerve which causes the patient’s heart
rate to return back to normal, omitting the need for administration of atropine. The
anesthesia provider acted responsibly in response to the bradycardia. However, the fact
remains that not only was that patient charged for a drug that they never actually
received, but the drug is now wasted after the procedure, which increases the overall cost.
Another example involves a patient who suddenly has a fairly common
complication called laryngospasm during extubation. It is imperative that if the spasm
cannot be broken with other methods, that paralytic be given in order to ventilate the
patient, as in the example previously presented of little Jacobi Hill. This is not the time
to have to turn your back on a patient and take minutes to draw up succinylcholine while
the patient is de-saturating because their anesthesia provider cannot hold positive
pressure due to the fact that they are too busy drawing up medication. It is clear to see
how much safer it would be for a patient to be protected by a policy that could foresee
issues and prevent ADEs ahead of time and standardized pre-filled syringes for
immediate administration.
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Review of Related Literature
A systematic literature review was conducted to direct, design, and develop this
capstone project using the Agency for Healthcare Research and Quality (AHRQ), the
Cumulative Index of Nursing and Allied Health Literature (CINAHL), Cochrane Library,
Centers for Medicare and Medicaid Services (CMS), JCAHO, the CDC, the AANA,
EBSCO, and other evidence based resources.
The PICO question that guided this literature review and project was: In patients
undergoing surgery, who require anesthesia, do vial-filled medication delivery systems
potentiate a risk to patient safety, decrease outcomes, increase medication waste, and
increase cost of healthcare? A literature review was used to determine if measures were
taken to have pre-filled syringes prepared in an anesthesia drug tray, would that result in
a safer, more cost-effective practice with less medication errors, less drug delays, and
faster turnover.
In 2010, JCAHO released updated labeling criteria to be followed in procedural
areas. The 2010 National Patient Safety Goals state that “when a drug is drawn into a
syringe or otherwise used from its original container it must be immediately
administered. ‘Immediate administration’ means with no intervening steps or functions
prior to administration. [They further outline labeling medications and solutions in the
context of NPSG.03.04.01 which state that] the labeling expectation for this safety goal
are consistent with the requirements which state that the label must include: The drug
name, strength, and amount, expiration date when not used within 24 hours, expiration
time if less than 24 hours (which applies to only a few drugs), as well as the date
prepared and diluents for all compounded IV admixtures. [In light of these safety goals,
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the Joint Commission] approves the purchase and use of pre-filled, pre-labeled syringes
such as on procedure trays.” (The 2010 National Patient Safety Goals, 2010, pp. 5-6)
The CDC Infection Prevention Checklist for Outpatient Settings: Minimum
Expectations for Safe Care states that “Injections are prepared using aseptic technique in
a clean area free from contamination or contact with blood, body fluids or contaminated
equipment” (CDC, 2013, p. 6). This means that medication should be drawn and labeled
outside of patient areas, including the operating room. This is virtually never adhered to,
and never will be, as long as the anesthesia providers use vials that must be drawn up
when conditions mandate their administration. There is an obvious contradiction
between the current practice standards and the CDC’s guidelines.
“Operating rooms and the perioperative area are the most medication-intensive
areas in a hospital. These areas use more medications, especially high-alert medications,
than any other unit, but operate with fewer safety measures in place” (Brown, 2014, pp.
466). The Anesthesia Patient Safety Foundation’s (APSF) new standard of medication
administration includes further safety measures that exceed the standard Joint
Commission recommendations of labeling and visual verification of labels. “Pre-filled
syringes and standardization of medications, workstations, and technology have been
shown to reduce the number of Adverse Drug Events (ADE) by at least 21% and, in
certain institutions, by much more than 21%. The available information is sufficient to
promote the implementation of pre-filled or premixed syringes in anesthesia departments
to reduce the number of ADEs and become compliant with the APSF, Joint Commission,
and Institute of Medicine” (Brown, 2014, pp. 465-469).
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To provide additional evidence for practice, the APSF states that high alert drugs,
such as phenylephrine and epinephrine, used routinely by anesthesia providers, should be
available in standardized concentrations and/or diluents prepared by pharmacy in a readyto-use syringe and should have standardized, fully compliant, machine readable labels.
They continue to include that “routine provider-prepared medications should be
discontinued whenever possible. Clinical pharmacists should be part of the operating
room team, and standardized pre-prepared medication kits by case type should be used
whenever possible” (Eichhorn, 2010).
According to the World Health Organization (WHO), applicable legislation is
defined as the instrument by which the implementation of a drug policy is given a legal
basis by statutorily defining the various strategies for achieving the objectives of the
policy. It also defines the qualifications, duties, privileges, and obligations of
individuals, organizations, and institutions. “For the effective implementation of
legislation, there is a need to review and update the relevant laws regularly, in
consultation with relevant stakeholders (such as pharmaceutical companies, anesthesia
providers, and surgical patients), in order to achieve the desired objectives. Some of the
existing drug laws are in dire need of review and harmonization” (National Drug Policy,
2005, p. 14).
The wave of the future is pre-filled syringes and pre-filled, pre-labeled syringe
filled anesthesia drug trays. The American Association of Nurse Anesthetists’ AANA
News Bulletin (2015) highlighted pre-filled syringes in anesthesia practice. They cited
companies, such as PharMEDium, who pay tribute to their specific pre-filled, pre-labeled
syringe, which utilize the American Society for Testing and Materials standard for color
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differentiation of anesthesia syringe medications, endorsed by the American Society of
Anesthesiologists (p. 36).
Differentiating color is a helpful visual differentiating tool but color alone it is not
enough to distinguish medications within a class, so the medication name was
implemented in six different locations to guarantee the most crucial information is
observable from any angle. They further added specific consistent lettering suggested by
the Institute for Safe Medication Practices (ISMP), and a variety of visual cues, including
shapes and reverse print to create a conspicuous layout proposed to support medication
administration in emergency situations. After completing a widespread facility
investigation of existing practice and previous medication errors to improve the OR label
draft, syringe labels now include drug name on circular rings and vertical stripes
alongside graduated inscription, guaranteeing the medication name is visible during drug
selection but also through administration when the principal focal point is on the
graduated marks (PharMEDium, 2014). Quality improvements include the
implementation of sterile, industrially accessible medication in ready-to-use medication
syringes.
The European Board of Anesthesiology (EBA) recommendations for safe
medication practice state that “all medications need to be prepared for routine use in
anesthesia, intensive care, and emergency medicine and pre-filled syringes should be
used wherever possible” (EBA recommendations for Safe Medication Practice, 2011 p.
294). Research provided many studies revealing evidence of utilization of pre-filled
syringes, especially in an article entitled “Medication Errors during preparation and
treatment delays.” The objective was to examine medication errors that occurred during
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the preparation and administration of medication used in an intensive care unit. The
analysis was carried out in a 12-bed ICU and data, were composed over 16 randomly
selected days at various medication times. A skilled spectator worked alongside the
nurses during medication rounds. Errors were recorded during the inspection period of
medication administration and preparation. Drugs most used in the ICU were selected.
Information about the method of preparation and administration of the chosen
medications were analyzed against a checklist, which was organized using manufacturers'
instructions. Out of 524 preparations and administrations, the calculated number of
opportunities for error was 4040. Identifiable errors were 380/4040, (9.4%), and of those,
33.6% were associated to the preparation process and 66.4% with the administration
process.
Clinically relevant outcomes were assessed, and the risk and benefits of the
treatment were noted, and while it is clear that medication errors would be reduced and
treatment delays improved, this method would have considerable monetary implications
for healthcare providers. Further research is needed in the area of cost effectiveness.
Lastly, the expectation is safe, effective, first-rate treatment. “Providing infusions in prefilled syringes would reduce medication errors and treatment delays, improve patient
safety, and effectively meet these expectations” (Fahimi et al., 2008, p. 104).
According to Dr. Stratman, lead researcher from Barnes-Jewish Hospital, “the use
of pre-filled, pre-labeled syringes likely will be cost neutral to the hospital, with the costs
of outsourcing medications offset by the savings in otherwise wasted drugs. But when
you look at the impact of the initiative on quality and safety for the patients … it’s what’s
right to do even if it costs a little more” (Blum, 2013, p. 3).
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Further incidence of medication errors and treatment delays were directly
evaluated in a study analyzing errors during the preparation of medication. The
background considered the degree and regularity of errors and treatment delays made as a
result of bedside preparation, instead of using pre-filled syringes. Forty-eight ICU nurses
volunteered in this randomized, blinded, controlled study carried out in a metropolitan
hospital. Medications were drawn from concentrated vials, or they were provided in prefilled syringes beforehand.
They compared both preparation time and concentration of the medication against
medication prepared by pharmacists. It took nurses 156 seconds to initiate infusions
when using pre-filled syringes compared with 276 seconds when preparing them from
vials, averaging a delay of 106 seconds. When using pre-filled syringes, medication
errors were 17 times less likely and they resulted in a reduction of medication errors and
treatment delays while simultaneously improving patient safety (Adapa et al., 2012).
The pre-labeled syringes saved money and time, and increased patient safety. The
review supports the need for further study in order to determine each locations specific
monetary value of medication errors. The results will help providers care for patients as
patient safety and safe medication administration can directly be applied into clinical
practice. Standard medication labels should be available to the provider to improve
patient safety (Adapa et al., 2012).
In a letter written by a group of notable anesthesia providers, ranging from noted
authors, CRNAs, and MDAs, there were a list of recommendations and requested
revisions made to the JCAHO written requirements. They stated that they had exceptional
concerns with exclusion on pre-labeled syringes, identification of spinal and epidural
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medication via labeling, and the label authentication requirements when two providers
are involved. They gave specific reasons for their requests, and it was clear, based on
their argument, that changes needed to be made to the JCAHO recommendations and
requirements. The overturning of policies and procedures as outlined improves patient
safety and efficiency of practice (Santoro, Stoelting, Wagner, & Warner, 2010).
A study in an OB unit in France examined the use of ephedrine pre-filled syringes
and concluded, with valid evidence, that they did indeed reduced anesthesia costs. It
evaluated the utilization, expense, and consumption of ephedrine against the use of
ephedrine via pre-filled syringes. The expense included vials and consumable equipment
against pre-filled syringes and results were evaluated on the base of cost. Over one
hundred parturients were evaluated in the study. They found that 155 vials were used for
verses 45 pre-filled syringes. The outcomes of the study demonstrate that the use of prefilled syringes considerably reduced medication waste and decreased cost in OB
anesthesia. The results showed that the use of pre-filled syringes significantly reduced
the wastage of ephedrine, allowing subsequent cost minimization in obstetrical anesthesia
(Bellefleur et al., 2009). If it were possible to ensure that the pre-filled syringes were
used for “immediately for bradycardias… then the pre-filled syringes [would] save
money” (De Mello & Vipond, 2000 p. 303).
In conclusion, The U.S. National Library of Medicine states that in 2008 the annual
cost of measurable medical errors that harm patients was $17.1 billion and the second
most common medication error is dilutional drug errors (U.S. National Library of
Medicine National Institute of Health, 2011).
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A new policy in favor of standardization of pre-filled syringes and pre-filled
anesthesia drug trays would significantly reduce medication waste and decrease cost. By
simply changing the policy on the delivery system, and nothing else about a given
providers practice, cost is decreased, medication waste among anesthesia providers
becomes significantly decreased, patient safety is enhanced, induction time is decreased,
and the providers job is more streamlined.
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CHAPTER II
METHODOLOGY
Design and Target Population
In establishing a comprehensive cost benefit analysis, comparing a sample prefilled anesthesia drug tray against a vial-filled drug tray, recommendations, standards,
and guidelines were compiled to show a shift toward pre-filled, pre-labeled syringes. In
2010, JCAHO released updated labeling criteria to be followed in procedural areas. In an
effort to comply with The 2010 National Patient Safety Goals, “when a drug is drawn
into a syringe or otherwise used from its original container it must be immediately
administered with no intervening steps or functions prior to administration” (The 2010
National Patient Safety Goals, 2010, p. 5). They further outline labeling medications and
solutions in the context of NPSG.03.04.01 which states that “the labeling expectation for
this safety goal are consistent with the requirements which state that the label must
include: The drug name, strength, and amount, expiration date when not used within 24
hours, expiration time if less than 24 hours, which applies to only a few drugs, as well as
the date prepared and diluent for all compounded IV admixtures”. In light of these safety
goals, JCAHO promotes the purchase and use of pre-filled, pre-labeled syringes such as
on procedure trays (The 2010 National Patient Safety Goals, 2010).
As previously stated, the CDC Infection Prevention Checklist for Outpatient
Settings: Minimum Expectations for Safe Care state that “Injections are prepared using
aseptic technique in a clean area free from contamination or contact with blood, body
fluids or contaminated equipment” (CDC, 2013, p. 6). Therefore, medication should be
drawn and labeled outside of patient areas, including the operating room.
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According to the AANA (2014), “operating rooms and the perioperative area are
the most medication-intensive areas in a hospital. These areas use more medications,
especially high-alert medications, than any other unit, but operate with fewer safety
measures in place” (p. 465). The APSF new model of medication administration includes
further protection to surpass the JCAHO recommendations of labeling. “Pre-filled
syringes and standardization of medications, workstations, and technology have been
shown to reduce the number of ADEs by at least 21% and, in certain institutions, by
much more than 21%. The available information promotes the implementation of prefilled syringes in anesthesia departments to reduce the number of ADEs and become
compliant with the APSF, the Joint Commission, and Institute of Medicine” (Brown,
2014, pp. 465-469).
Detailed Procedures
In an effort to meet the various recommendations and guidelines, an initial
baseline was established to include a set of specific medications, with specific dilutions,
labels, and quantity of each. A list of 37 anesthesia drugs, used by various facilities
throughout Mississippi, was formulated. Next, a comprehensive analysis compared the
current vial-filled medication administration of a regional medical center in south
Mississippi against pre-filled syringes. The specific dilution of each medication, the
concentration of each vial, and the cost of each medication were identified. Specific
variables were compared to offer the most cost-effective option for this specific facility.
Specific information gathered included a description of the most frequently used
medications, vial cost, cost of preparation and supplies such as blunt needles and empty

17
syringes, and monthly volume of specific medication administration (See Appendices A
and B).
Setting and Evaluation
Once this information was compiled at a facility in south Mississippi,
recommendations were made to change only what would benefit the facility. For
example, if a particular medication was rarely used or if the pre-filled medication might
expire before the providers thought they would be able to administer the syringe, that
syringe was not recommended for change from vial to syringe. The analysis included all
commonly administered anesthetic medication against pre-filled syringe availability, cost,
and expiration. A list of medications was compiled in a cost benefit analysis and a
medication tray provided to ensure that medications were always in the same location to
ensure safety and to streamline delivery. For example, the provider knows, almost
without having to think about it, that the Rocuronium is always located in the top right
corner, red in color, in a 5ml syringe at a dilution of 10 mg/ml. This way, no matter
which OR the provider practices in, the medication is the same every time. The direct
cost was compared between each vial and the counterpart syringe. Final calculations
were made and revealed significant decrease in cost of both individual pre-filled syringes
and the finalized anesthesia drug tray. These findings, however, represented only the
direct cost. Further substantial financial savings were identified to include indirect cost
benefit of pre-filled syringes. Lastly, providers were interviewed to discuss the positive
and negative aspects of pre-filled syringes, and potential room for improvement.
Feedback was then taken from the providers, and all of the paralytics were changed to
vary in color instead of all being red in color, following the recommendations of the
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providers. This was the only notable recommendation from the providers. These data
were utilized in the results section for the Business Plan.
Table 1
The Essentials of Doctoral Education for Advanced Nursing Practice

DNP

Fulfillment of DNP Essential

Essential

I

The specific scientific underpinnings for practice:
The benefits to the practice of anesthesia are evident in the direct and
indirect cost benefit analysis. The research shows that pre-filled
syringes increase safety, decrease medication waste, and is more costeffective than vials. Furthermore, regulations and recommendations of
governing bodies encourage automated dispensing systems and prefilled syringes in the future.

II

Organizational and systems leadership for quality improvement and
systems thinking:
Quality improvement measures were utilized in multiple research
articles, and prove that pre-filled syringes, when implemented,
improve quality and safety while decreasing the cost of healthcare by
significantly decreasing drug waste and dilutional medication errors.

III

Clinical scholarship and analytical methods for evidence-based
Practice:
Despite the need for further quantifiable research, the implications of
existing 17.1 billion dollar medication errors were used to show
obvious results of the analysis.

IV

Information Systems/Technology:
Patient Care Technology for the cost benefit analysis shows that by
simply changing nothing more than the packaging technology used to
deliver medication multiple systems are significantly improved.
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Table 1 (continued).

DNP

Implications for Pre-filled syringes

Essential

V

Improvement and Transformation of Health Care:
The implementation of pre-filled syringes offer the promise of
transforming and improving health care via improved quality and
safety and decreased cost of healthcare in the areas of significant
decrease of drug waste and dilutional medication errors.

VI

Health Care Policy for Advocacy in Health Care:
Evidence showing pre-filled syringes’ ability to improve healthcare
provides the foundation for unassailable advocacy for improved
outcomes, which should be the basis of health care policy

VII

Interprofessional Collaboration for Improving Patient and Population
Health Outcomes:
In order to successfully coordinate a comprehensive cost benefit
analysis to improve outcomes, interprofessional collaboration is
essential

VIII

Clinical Prevention and Population Health for Improving the Nation’s
Health:
Pre-filled syringe implementation dramatically drive the cost of the
nation’s health care down and clearly prevent costly medication errors
while simultaneously improving ease of practice for anesthesia
providers
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CHAPTER III
RESULTS
Reliance Pharmaceuticals & Consulting Business Plan
Based on the research that shows the superiority of pre-filled syringes, reliance
Pharmaceuticals was created to bridge the gap between the research and clinical practice.
Reliance Pharmaceuticals is a company that manufactures customizable pre-packaged
drug trays or other drug delivery systems and consults for drug delivery systems. We
have a compounding pharmacy under contract to draw up and pre-package syringes,
specifically organized for anesthesia providers’ unique needs based on their drug usage,
setup, and dispensing system.
Mission
Our Mission is to provide superior products for superior outcomes. We aim to make
available superior pharmaceutical products with improved value to anesthesia providers
and other users, advancing patient care and improving the quality of anesthesia and
healthcare. Our goal is to be the nation’s largest privately held and one of the fastest
growing distributors of pre-filled syringes in the United States. Our focus is serving
hospitals, surgery centers, physician offices and other health care markets.
Objectives
Our objectives are to be fully founded by October 2015, reach 7 contracts locally,
followed by a spread of contracts in the state of Mississippi, followed by contracts
regionally, and ultimately nationally. Customer satisfaction is at the cornerstone of our
business and is measured by anesthesia surveys, return customers, and increased sales.
We endeavor to guide our profession with the most cost-effective medication and
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invaluable clinical solutions for anesthesia providers and their patients, while advancing
superiority and efficacy in each part of our process.
This is a growing industry, starting locally and working toward national
distribution. Short-term goals include moving from vial-filled trays to pre-filled syringe
trays, while long-term goals are standardization of pre-filled syringe drug trays within the
operating room. Such standardization will thus augment our sales. Strengths include
providing an opportunity to increase operating room turnover rates and decrease
medication related errors and infections, and decrease drug administration delays.
Recommendations from the CDC and Joint Commission further strengthen our overall
goal toward safer, more streamlined practice. Once implemented, hospitals and
anesthesia providers will see the benefit of pre-filled syringes first hand. As anesthesia
providers ourselves, we have experienced the lag time of having to gather and prepare
medications between cases. We bring this experience and understand the urgency in
emergency situations.
Our goal is to become a Limited Liability Corporation. We have selected this form
because we blend elements of partnership and corporate structures. Partnerships are
between compounding companies and anesthesia providers. We blend the corporate
structure of CEO, CFO, VP of sales and marketing, and VP of public relations with the
partnerships between compounding pharmacies and anesthesia provider.
Guidelines, Standards, and Recommendations
In 2010, the JCAHO released updated labeling criteria to be followed in
procedural areas. In an effort to comply with The 2010 National Patient Safety Goals,
“when a drug is drawn into a syringe or otherwise used from its original container it must
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be immediately administered with no intervening steps or functions prior to
administration” (The 2010 National Patient Safety Goals, 2010, p. 5). They further
outline labeling medications and solutions in the context of NPSG.03.04.01 which state
that “the labeling expectation for this safety goal are consistent with the requirements
which state that the label must include: The drug name, strength, and amount, expiration
date when not used within 24 hours, expiration time if less than 24 hours (which applies
to only a few drugs), as well as the date prepared and diluent for all compounded IV
admixtures”. In light of these safety goals, the JCAHO approves the purchase and use of
pre-filled, pre-labeled syringes such as on procedure trays. (The 2010 National Patient
Safety Goals, 2010).
The CDC Infection Prevention Checklist for Outpatient Settings: Minimum
Expectations for Safe Care state that “Injections are prepared using aseptic technique in a
clean area free from contamination or contact with blood, body fluids or contaminated
equipment” (CDC, 2013, p. 6). This means that medication should be drawn and labeled
outside of patient areas, which would include the operating room.
According to the AANA (2014), “Operating rooms and the perioperative area are
the most medication-intensive areas in a hospital. These areas use more medications,
especially high-alert medications, than any other unit, but operate with fewer safety
measures in place” (p. 465). APSF new model of medication administration includes
further protection to surpass the regular JCAHO recommendations of labeling. “Prefilled syringes and standardization of medications, workstations, and technology have
been shown to reduce the number of Adverse Drug Events (ADE) by at least 21% and, in
certain institutions, by much more than 21%. The available information is sufficient to
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promote the implementation of pre-filled or premixed syringes in anesthesia departments
to reduce the number of ADEs and become compliant with the APSF, Joint Commission,
and Institute of Medicine” (Brown, 2014, pp. 465-469).
High alert drugs, such as phenylephrine and epinephrine, should be available in
standardized concentrations/diluents prepared by pharmacy in a ready-to-use (bolus or
infusion) form and ready-to-use syringes and infusions should have standardized fully
compliant machine– readable labels. Furthermore, “Routine provider-prepared
medications should be discontinued whenever possible. Clinical pharmacists should be
part of the perioperative/operating room team, and standardized pre-prepared medication
kits by case type should be used whenever possible” (Eichhorn, 2010, p. 25).
Products and Services
Our product involves a consolidation of commonly used, and some uncommonly
used, medications in shrink-wrapped, pre-filled syringes in a cut-foam insert within a
plastic tray and/or pre-filled syringes in automated delivery systems such as Pyxis or
Omnicell. We will have our syringes pre-filled and prepared at our contracted
compounding pharmacy that will guarantee the expiration dates and the highest quality
compounding and sterilely in our prepared syringes. Per the CDC and JCAHO
guidelines, our trays will have pre-filled and pre-labeled syringes that bypass human error
and improve safety and efficacy of the anesthetic process and thus significantly decrease
medication errors, drug waste, and response time during emergency situations, while
increasing room turnover rates, and continuity of care.
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Reliance Pharmaceuticals four key areas of Service
1.

Assessment:

Reliance Pharmaceuticals’ dedicated operating room specialists are trained to help assess
your individual needs. Each consultation will include a confidential detailed observation
report to help you evaluate drug usage and waste. Evaluations of medication usage are
utilized to support implementation of pre-filled syringes based on the hospital’s goals for
improving medication safety and process efficiencies. The assessment ensures an
improved compliance among The JCAHO as it pertains to labeling and USP 797.
2.

Development:

The Reliance operating room specialist will include input from both pharmacy and
anesthesia to develop custom medication tray layouts to support a comprehensive
solution.
3.

Maintenance:

The Reliance operating room specialist will provide ongoing support to ensure optimal
integration.
4.

Implementation:

Reliance specialists will assist with every step of the implementation process to support a
smooth safe and efficient process. A detailed implementation timeline is provided to help
ensure a seamless transition to Reliance ready-to-use services.
Benefits:
1.

Seamless Integration:

The dedicated Reliance operating room specialist will provide you with a customized
solution that meets pharmacy and anesthesia requirements.
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They will assist you through every step of the process to ensure a smooth transition to
ready-to-use medications.
2. Compatible Storage Solutions:
Reliance’s ready-to-use syringes are compatible with medication trays designed for
anesthesia carts, as well as the most commonly used automated dispensing cabinets,
including mini-drawers for controlled substances.
2.

Evaluation:

The confidential consultation will help identify opportunities to reduce drug waste and
determine which Reliance preparations offer the best overall value for your needs.
3.

Standardized Drug Tray Design:

Medication trays in various colors can be used to further differentiate the specialty trays
from the general surgery trays.
Marketing Plan and Economics
In order to succeed, effective marketing and branding are essential. This begins
with vigilant, methodical investigation. It is precarious to take for granted that our
company already knows about our anticipated market. Significant market research was
gathered and primary as well as secondary marketing research was utilized. Data
collection were procured from the Cochrane Library, CINAHL, MEDLINE, governing
anesthesia entities, professional associations and professional publications provided
industry-specific data, and local hospital demographics were critical in defining the local
market. Specific methodologies outlined comparison between current trends and
proposed changes. Information was packaged for presentation to key stakeholders and
decision makers at each given facility.
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Our initial market consists of seven locations within the greater Hattiesburg area
including Forrest General Hospital, Larry A. Woodall, Orthopedic Institute, Southern
Bone and Joint, Wesley Medical Center, Hattiesburg Eye Clinic, and Southern
Anesthesia. In addition to the initial seven facilities, five other facilities will provide
opportunity for growth including ambulatory surgery centers, plastic surgery centers,
Hattiesburg GI associates, and Southern Eye Center.
Table 2
Variable Shipping Costs

Facility

Variable number of drug trays used daily

Forrest General Hospital

50

Larry A. Woodall

25

Orthopedic Institute

25

Southern Bone and Joint

25

Wesley Medical Center

50

Hattiesburg Eye Clinic

25

Southern Anesthesia

50

Reliance Variable Profit: 205 Trays (daily): Cost and Profit breakdown: $0.50 per medication, $5-15 dollars per tray, average 205
cases daily for all accounts equals $2,050 daily, multiplied x 7 days a week is $14,350 per week, multiplied x 52 weeks in a year =
$746,200 annually. A $0.05 discount per syringe to Reliance is negotiated from contracting compounding pharmacy. (NOTE: not all
drugs from every tray will be used for any given case, therefore Reliance profit is variable depending on any given surgical case)
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Reliance has 7 out of 11 facilities offering surgical services within the greater
Hattiesburg area. This yields a 58% market share. Prior to standardization of pre-filled
syringes (our long term goal), there is an undetermined demand, however, our goal is to
create a high demand where there is none now. Current trend is vial use from prepackaged anesthesia drug trays in which the provider prepares each medication
individually as needed. Unfortunately this, more often than not, is done is such a way to
violate the guidelines and recommendations set by the governing entities. Pre-filled
syringes are used in O.B suites and trauma suites but there are no pre-packaged drug trays
with pre-filled syringes at these locations currently. Our goal is to secure local facility
contracts and then grow statewide, regionally, nationally, and eventually standardize prefilled syringes, where we will already have the majority of the market share. Potential
barriers include contract negotiations, future competition, and adequate patenting.
Table 3
Capital costs and Startup expenses

Factor

Monthly Cost

Furnished Office building deposit

$2000

Utilities deposit (electric, sewage, internet, water, phone)

$500

Webpage setup

$500

Travel Expenses $2,795(gas), $400 (food)

$3195

Rent

$1000

Attorney fee (annually) / contracts, etc. $250/hr x 2 hrs each x 6
occasions: $1500 + LLC (annually) $800 = $2300

$192
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Table 3 (continued).

Factor

Monthly Cost

CPA (Monthly)

$500

Webpage maintenance

$200

Patent on pre-filled drug tray (one-time fee)

$500 - $10,000

To avoid potential financial barriers, high costs of both drugs and shipping will be
transferred to the hospital or surgery center, who can then transfer the cost to each patient
once drugs are used (Reliance system helps ensure that all charges are captured to
facilitate this transfer.) Specific cost analysis is outlined (Appendix A). To address
potential barriers associated with patenting our product, wholesale prices are negotiated
and order in bulk to reduce cost to the healthcare facility. This would prevent the
provider from ordering directly from our wholesaler. If the government standardizes prefilled syringes, a monopoly would exist on anesthesia drug trays in our local market. If
the economy suffers, hospitals might be prone to cut costs, including seeking out the
cheapest (not necessarily the best or safest) drug options. Hopefully, standards,
guidelines, and recommendations will bring about standardization and such change will
bring about pre-filled syringe standardization.
Contracts are to be extended three to six months based upon the need of each
individual facility. Warranty, refund, and quality responsibility are transferred to the
manufacturer/compound pharmacy who guarantees the quality of their dilution, labeling,
measurement, life expectancy and sterility. Shipment will be handled directly by the
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compounding pharmacy. Our initial market consists of 7 locations within the greater
Hattiesburg area including Forrest General Hospital, Larry A. Woodall, Orthopedic
Institute, Southern Bone and Joint, Wesley Medical Center, Hattiesburg Eye Clinic, and
Southern Anesthesia.
Our competition would be drug tray distribution companies who distribute filled
vials instead of filled syringes. Other competition would be drug dispensing system
companies such as Pyxis and Omnicel.
They will be competitive in cost and they also have the market now. Our biggest
challenge will be getting the decision makers to choose our drug trays.
Table 4
Competitive Analysis Table

Factor

Reliance

Strengths

Weaknesses

Competitor A

Competitor B

Products

Superior

Compliant
Safety, $,
Labels,
Dilution,
Speed

Expensive

Vials

Pre-labed,
Pre-filled,
Pre-packaged

Price

Variable

Saves $ More
med errors expensive
/ turn-over initially
time

Variable

Variable

Quality

Superior

Same as
N/A
less
effective
competitor

N/A

N/A
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Table 4 (continued).

Factor

Reliance

Strengths

Appearance

Pre-filled
immediate
ly
available

Sales
Method

Weaknesses

Competitor A

Competitor B

Immediate N/A
available

Familiar vials

Pre-filled
immediately
available

Direct
B2B sales

Personal

Potential
loss of
business

Equal

Equal

Advertising

Direct
B2B

Personal /
Reliable

Less
popular

Nation Wide
commercials

Trusted,
reliable,
familiar

Image

Equal

Equal,
Compliant

N/A

Vials –
familiar

Equal

Selection

Equal

Equal

Equal

Equal

Equal

Stability

Equal as
long as
they used
the vial
correctly

Equal

Equal

Equal

Equal

Expertise

Equal

Equal

Equal

Equal

Equal

Reputation

Weakness, New and
must
Evidence
establish a Based
reputation

New and
unknown

Known,
respected,
trusted

Bright Future
(EBP)

Our niche corner of the market is a pre-filled, pre-labeled, pre-packaged
anesthesia drug tray. Pre-filled pre-labeled syringes cut down on costly medication
errors, decreased contamination, due to their being drawn under a sterility hood,

31
decreased draw-up time, and decreased room turnover time. This enables us to have the
market share of competition in our targeted area with the ability to expand statewide,
regionally and nationally with ultimate standardization of our product, which will give us
a monopoly on the market. Our marketing strategy will be targeted, marketed, scheduled
presentations at local facilities.

LANCE KENNEDY
CEO

(601)-480-7978

RELIANCE
PHARMACEUTICALS

105 MARSHALL PLACE HATTIESBURG, MS. 39402
RELIANCE.PHARMACEUTICALS@GMAIL.COM

Figure 1. Business Card Design with bright blue and black color scheme to augment the
operational plan and promotion
All syringes will be pre-packaged via contracted compounding pharmacy.
Quality is guaranteed via individual compounding pharmacy that prepare the syringes
under sterile, hooded conditions. Customer service will include and ensure that each
facility has adequate supply, ability to replace damaged syringes, and an open line of
communication for questions/comments and restock requests. Monthly and weekly
medication usage statistics for each drug will be requested from each facility and will be
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coupled with specific short-term inventory requests. The amount of space needed will be
minimal. Trays will be completed per order due to expiration constraints. No building
will be needed for medication tray storage, as they will be shipped directly from
compounder to facility. Business hours will be Monday through Friday from 8am to 5pm
with 1 person on call 24 hours a day, 7 days a week including holidays, should an
emergency surface.
Permit to dispense and distribute medications. This is placed in the hands of the
compounding pharmacy. Medication control, dispensing and distributing are regulated
and records of each medication and amount must be recorded and filed. Liability
insurance will include $6000/year per million dollars of coverage. Trademarks
associated with completed anesthesia trays are still pending. Medical professionals,
specifically CRNAs, will be employed upon expansion. As the business grows,
employees will be interviewed with a minimum requirement being a CRNA with
adequate business experience. Original employees (4) will negotiate an equal salary pay
rate with additional payment for call schedule and overtime. On-the-job training will be
needed for new hires after a day of classroom time to cover basic protocol, substance
abuse training, and specific job requirements.
The beginning schedule will be all employees 8am-5pm Monday through Friday
with an on-call rotation including but not limited to: professional communication with
compounding pharmacy and health care facility, mediate sales and consulting and acquire
new business, process medication orders, must function in strict accordance with
standard, written procedures and guidelines with deviation approved by owner.
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Seasonal buildups are negligible since orders will be processed and produced
upon order request, and medications expire and lead-time will depend on the supply in
need and the current order load. Processing can be sent to an outlying compounding
pharmacy if the current pharmacy load is exceeded. Multiple compounding pharmacies
are contracted to avoid drug shortages and existing customers get priority in the event of
such drug shortages. Inventory furnished will be split evenly between compounding
pharmacies.
Contracted Compounding Pharmacies include Advantage Compounders located at
6375 U.S. Highway 98 West Suite 40 & 50 Hattiesburg, MS 39402 and Vital Care
Compounders located at 115 South 40th Avenue Hattiesburg, MS 39402. Delivery will
be arranged by our company to pick up the product and deliver it directly to the health
care facility. Sale is complete upon full payment of each order. Reliance
Pharmaceuticals retains their $0.50 per drug and remaining payment goes directly to
compounding pharmacy for order preparation. Credit will be used only if absolutely
necessary and must be approved by the owner. The creditworthiness of the healthcare
facilities will be determined by history of sales to that particular facility and remain at the
owners discretion. New accounts mandate initial full payment and where future credit
options are allowed, payment will be due within 30 days of product delivery. If late
payment is expected, a phone call is to be made within 30 days. A letter will be sent
when 7 days past due and at 30 days past due, attorneys will begin issuing letters.
Management and Organization
The three initial partners and investors will be responsible for managing specified
daily business as agreed upon via owner and final decisions are to filter through owner.

34
As Certified Registered Nurse Anesthetists, each partner will bring to the business an
understanding of the drugs used, clinical experience of how efficient and effective our
product is, and how well it will benefit the facility that purchases. In the event of conflict
among partners, owner retains final and ultimate authority. No loans will be applied for,
as initial startup costs are invested via owner and three partners/investors.
Table 5
Professional Advisory and Support

Service

Name

Owner

Lance Kennedy

Board of Directors

Lance Kennedy, Sayha Ma, Chris Turner,
Jarrod Fontenelle

Management Advisory Board

Patsy Anderson, Vicky Stuart, Bonnie
Harbaugh

Attorney

Jack Denton Law office PLLC

Accountant

James McDonnell, CPA

Insurance agent

Lance Ware (State Farm)

Banker

Wells Fargo

Consultants, Mentors, and key advisors

Board of Directors and Advisory Board
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CHAPTER IV
SUMMARY
The future of Anesthesia drug delivery is obvious, and, the data provide clearly
defined recommendations and guidelines. The research reveals overwhelming evidence
that the use pre-filled syringes would reduce medication errors and treatment delays and
improves patient safety outcomes (Fahimi et al., 2008). “When you look at the impact of
Pre-filled syringes and their impact on quality and safety for the patients, it’s what’s right
to do even if it costs a little more” (Blum, 2013, p. 3). Also, when using pre-filled
syringes, medication errors are 17 times less likely and would reduce medication errors
and treatment delays, and improve patient safety (Adapa et al., 2012). Pre-filled syringes
reduce significantly the wastage of medication, allowing subsequent cost minimization in
anesthesia (Bellefleur et al., 2009).
Summary of Findings
The U.S. National Library of Medicine states that in 2008, the annual cost of
measurable medical errors that harm patients was $17.1 billion, and the second most
common medication error was dilutional drug errors (U.S. National library of Medicine
National Institute of Health, 2011). Additionally, the implementation of pre-filled
syringes stands to decrease the cost of healthcare by $420,000,000 annually just from the
21% decrease in Adverse Drug Events (Brown, 2014, pp. 465-469). If it were possible
to ensure that the pre-filled syringes were used, then the pre-filled syringes [would] save
money (De Mello & Vipond, 2002, p. 303).
To reiterate, the 2010 National Patient Safety Goals state that “when a drug is
drawn into a syringe or otherwise used from its original container it must be immediately
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administered with no intervening steps or functions prior to administration” (The 2010
National Patient Safety Goals, 2010, p. 5). This makes pre-filled syringes an obvious
choice. As well, the CDC’s minimum expectations for safe care are that injections are
prepared outside of patient areas, which would include the operating room and as such,
pre-filled syringes are, again, the obvious solution (CDC, 2013). Furthermore, according
to the AANA (2014), “the available information is sufficient to promote the
implementation of pre-filled or premixed syringes in anesthesia departments to reduce the
number of adverse drug events and become compliant with the Joint Commission, and
Institute of Medicine” (Brown, 2014, pp. 465-469). It seems to be only a matter of time
before each individual operating room will be required to have its own automated drug
dispensing system or pre-filled drug tray.
Current policies on Drug storage simply mandate that an entity reasonably show
that they are adhering to vague medication storage standards. Anesthesia drug policy,
storage, and distribution are decided on by each individual facility with minimal attention
to detail. If current healthcare policy would ensure the use of pre-filled syringes, their
standardization would immediately begin to improve outcomes and healthcare cost would
be immediately decreased.
In the OR, precision and split second decisions are essential to the quality of
patient care. Instead of relying on vague policy options to steer the quality of anesthesia,
policy should be created where pre-filled syringes are utilized with pharmacy prepared
labels that are intended to augment medication name identification during potentially
grave circumstances. Further recommendation values policies that included standardized
color differentiation, easy to read labels with graduated markings, dilution, and expiration
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dates that would increase quality, speed and efficiency, and dramatically reduce drug
waste.
Implications for Nursing Practice
Reliance Pharmaceuticals specializes in pre-filled, pre-labeled, and prepackaged
syringes and consulting. They show how to save the contracting facility approximately
one million dollars per year and how to significantly decrease dilutional drug errors, drug
wastage, and ADEs from an anesthetic point of view. Let’s take a look at how we do
this. Dilutional errors are the second most costly medication errors. Although this may
be true, there is room for improvement. The national average of these errors are $21
billion dollars per year. Mississippi’s average of medication errors is $420 million
dollars. The estimated per hospital medication errors equal $3.5 million dollars. Twentythree percent of dilutional errors come to the average of $805,000 dollars. In addition to
dilutional errors, average drug wastes for the surrounding hospitals are $42,000 a year.
The total savings for increased room turnover, based on research is: 1.85 minutes per
case. The average case count in a day of the projected initial hospital contract caseload is
53 cases a day. In an effort to use conservative, realistic numbers if 50 cases a day times
1.5 minutes = 75 minutes a day, 75 minutes times 7 days a week = 525 minutes. 525
minutes times 52 weeks in a year = 27,300 minutes = 455 hours 11.375 work weeks you
will get about three months back which equals up to $70/hour x 455 hours = $31,850.
The cost of an anesthesia tray of vials is $313 dollars. The time to administer a
pre-filled syringed drug is 13 seconds, whereas it takes 35 seconds to administer a vial
drug. How much money is our business making? Initially, $0.50 per medication, $5-15
dollars per tray, average 205 cases daily for all accounts, $2,050 daily x 7 days a week
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$14,350 per week x 52 weeks in a year = $746,200 annually. Our compounding
pharmacy pitch: 205 cases daily x seven days a week = 1,435 cases a week x 52 weeks in
a year = 74,620 cases a year (less unused, redistributed medications). $13,431,600 per
year is paid to the compounding pharmacy.
Conclusion
The dynamic practice of anesthesia necessitates relentless assessment to generate
safeguards. While modification is not always essential, evaluating an organization and
looking for cost-effectiveness and improved patient care measures can be advantageous
in treatment of illness, in the facility, and in the entire profession of anesthesia.
Standardization provides consistency and a universal system, which improves patient
safety and can lead to departmental cost savings. In the mission to continually improve
our practice and patient care during anesthesia, let us hold diligently to the guiding
principles that catapulted our profession to where it is today. This continued approach
should lead us to a standardization of pre-filled, pre-labeled syringes in prepackaged drug
trays customized to the individual needs of a given facility. The ability to put aside
selfish ambition and strive for the greater good will highlight the principles of delaying
gratification, character, integrity, and dedication to success that has bought and will
continue to bring out the very best in us, as anesthesia providers, and in healthcare
throughout the nation.

APPENDIX A
MEDICATION EVALUATION TABLE

Description Vial
Cost

Preparation Total
Current
Supplies
Preparation Monthly
Cost
Volume

Current
Monthly
Cost

Estimated
Pre-filled
Monthly Usage Syringe
post Syringe
Price
Implementation

Monthly
cost for
Pre-filled
Syringe

Financial
Difference

Phenylephrine

$4.50

$0.50

$5.00

66

$330.00

40

$4.81

$192.40

-$137.60

Ephedrine

$10.19

$0.50

$10.69

76

$812.44

46

$12.78

$587.88

-$224.56

Vecuronium

$5.45

$0.50

$5.95

54

$321.30

69

$14.99

$1,034.31

$713.01

Cisatracurium

$13.76

$0.50

$14.26

61

$869.86

$0.00

-$869.86

Rocuronium

$8.19

$0.50

$8.69

51

$443.19

$8.62

$267.22

-$175.97

Neostigmine

$89.18

$0.50

$89.68

73

$6,546.64 44

$11.30

$497.20

-$6,049.44

Glycopyrrolate $25.87

$0.50

$26.37

92

$2,426.04 55

$30.81

$1,694.55

-$731.49

Lidocaine

$1.28

$0.50

$1.78

704

$1,253.12 422

$3.83

$1,616.26

$363.14

Epinephrine

$1.18

$0.50

$1.68

13

$21.84

8

$5.38

$43.04

$21.20

Midazolam

$1.37

$0.50

$1.87

186

$347.82

186

$4.52

$840.72

$492.90
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Impact

Total monthly impact

Annual Impact

ANNUAL Impact

-$6,598.67
-$79,184.04
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APPENDIX B
PHARMEDIUM SAMPLE LABELING TABLE

41
APPENDIX C
THE UNIVERSITY OF SOUTHERN MISSISSIPPI IRB APPROVAL
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APPENDIX D
PROJECT TIMELINE

Month

Activities

May 2013

Complete AANA wellness modules

August 2013

Complete Collaborative Institutional Training
Initiative (CITI)

September 2014
April 2015
July 2015
July 2015
July 2015
August – September 2015
September 2015
October 2015
October 2015
December 2015

Submit graduate committee chair and member names
(3) to NAP
Submit Institutional Research Board (IRB) application
for process approval
Application submitted for Degree and Plan of Study
Submit Contact Graduate Reader form to the Reviewer
of Graduate Nursing Capstone Projects
Defense of Proposal and submission of approval form.
Submission of title page
Data Collection
Capstone paper corrections.
Rework data interpretation
Final presentation/Capstone defense.
Submit copy of capstone project to Graduate Reader
for proofing and approval
Graduate
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